Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.75 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 4/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | DHODH | Q02127 | 1/20 | 0.51 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | FBP1 | P09467 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL805622 | 1.00 | AKR1C3 (0.75) | AKR1C3RECQLALDH1A1TSHRHTT | |
| SCHEMBL2532810 | 1.00 | AKR1C3 (0.75) | AKR1C3RECQLALDH1A1TSHRHTT | |
| SCHEMBL581982 | 0.86 | AKR1C3 (1.00) | AKR1C3RECQLALDH1A1TSHRHTT | |
| SCHEMBL16568719 | 0.86 | AKR1C3 (1.00) | AKR1C3RECQLALDH1A1TSHRHTT | |
| SCHEMBL37034 | 0.86 | AKR1C3 (1.00) | AKR1C3RECQLALDH1A1TSHRHTT | |
| SCHEMBL759656 | 0.86 | AKR1C3 (0.75) | AKR1C3RECQLALDH1A1TSHRHTT | |
| SCHEMBL759655 | 0.86 | AKR1C3 (0.75) | AKR1C3RECQLALDH1A1TSHRHTT | |
| SCHEMBL41906 | 0.86 | AKR1C3 (1.00) | AKR1C3RECQLALDH1A1TSHRHTT | |
| SCHEMBL23458002 | 0.85 | AKR1C3 (0.73) | AKR1C3RECQLALDH1A1TSHRHTT | |
| SCHEMBL6433811 | 0.85 | AKR1C3 (0.73) | AKR1C3RECQLALDH1A1TSHRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107935831-B | Method for catalyzing aldol condensation reaction by copper salt | 福州大学 | 2020-12-25 | — | — | CN | claimed |
| CN-107935831-A | A kind of method of mantoquita catalysis aldol reaction | 福州大学 | 2018-04-20 | — | — | CN | claimed |
| EP-2362765-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2011-09-07 | — | — | EP | claimed |
| WO-2010065446-A2 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2010-06-10 | — | — | WO | claimed |
| US-20100137178-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2010-06-03 | — | — | US | claimed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| US-4226682-A | UNSATURATED KETONE COMPOUND, NONIONIC WETTING AGENT | POPESCU FRANCINE | 1980-10-07 | — | — | US | claimed |
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2026-04-09 | — | — | US | disclosed |
| EP-4489592-B1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2025-12-24 | — | — | EP | disclosed |
| US-20250255827-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-08-14 | — | — | US | disclosed |
| EP-4593639-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | Xampla Limited (GB) | 2025-08-06 | — | — | EP | disclosed |
| US-20250186960-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-06-12 | — | — | US | disclosed |
| EP-3888782-B1 | COATED MICROCAPSULES | NOXELL CORP (US) | 2025-06-11 | — | — | EP | disclosed |
| EP-0975224-A1 | PROCESS AND COMPOSITIONS FOR ENHANCING RELIABILITY OF EXOGENOUS CHEMICAL SUBSTANCES APPLIED TO PLANTS | MONSANTO COMPANY (US) | 2000-02-02 | — | — | EP | disclosed |
| US-6020287-A | USING MIXTURE OF HERBICIDE AND PHENYL-SUBSTITUTED OLEFIN COMPOUND | MONSANTO COMPANY (US) | 2000-02-01 | — | — | US | disclosed |
| WO-1998033385-A1 | PROCESS AND COMPOSITIONS FOR ENHANCING RELIABILITY OF EXOGENOUS CHEMICAL SUBSTANCES APPLIED TO PLANTS | MONSANTO COMPANY (US) | 1998-08-06 | — | — | WO | disclosed |
| US-4582634-A | ORGANOLEPTIC | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1986-04-15 | — | — | US | disclosed |
| US-4507225-A | Process for augmenting or enhancing the aroma of perfume compositions, colognes and perfumed articles with 1-phenylpenten-4-one-1 and methyl homologues thereof | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1985-03-26 | — | — | US | disclosed |
| EP-0130313-A2 | Oligomers and homopolymers of meta- or para-isopropenyl-alpha,alpha-dimethylbenzylisocyanate | AMERICAN CYANAMID COMPANY (US) | 1985-01-09 | — | — | EP | disclosed |
| US-3989708-A | HYPOTENSIVE, CORONARY VESSEL DILATORS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | PCTP, CLK4, MTCL3 | AKR1C3 4869/4885RECQL 3658/4885ALDH1A1 4813/4885 |
| US-20100137178-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | AKR1C3 2071/4885RECQL 1265/4885ALDH1A1 1194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.